Literature DB >> 8997628

Vitamin C and E prevent lipopolysaccharide-induced apoptosis in human endothelial cells by modulation of Bcl-2 and Bax.

J Haendeler1, A M Zeiher, S Dimmeler.   

Abstract

Lipopolysaccharide induced apoptosis and necrosis of human umbilical venous endothelial cells in a time-dependent manner. Lipopolysaccharide (1 microgram/ml)-induced apoptosis was maximal after 18 h, whereas necrosis occurred after prolonged incubation for more than 24 h. The increase in apoptosis correlated with a reduction in Bcl-2, a potent cell death inhibitor. Furthermore, lipopolysaccharide treatment upregulated Bax, which heterodimerizes with and thereby inhibits Bcl-2. Both the antioxidant N-acetylcysteine and the combination of vitamin C and E (10 microM) completely inhibited lipopolysaccharide-induced apoptosis, whereas vitamin C or E alone was less effective. The reduction of lipopolysaccharide-induced apoptosis by vitamin C and E was paralleled by an increase in Bcl-2 and a decrease in Bax protein levels. Thus, vitamin C and E seem to interfere with the Bcl-2 family of apoptosis regulators in human umbilical venous endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997628     DOI: 10.1016/s0014-2999(96)00759-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  27 in total

1.  Functional heterogeneity of anti-endothelial cell antibodies.

Authors:  A Bordron; R Révélen; F D'Arbonneau; M Dueymes; Y Renaudineau; C Jamin; P Youinou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

2.  Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF-alpha-stimulated endothelial cells via a mitochondria-dependent pathway.

Authors:  K Nakatani; S Takeshita; H Tsujimoto; I Sekine
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

3.  Overexpression of human GPX1 modifies Bax to Bcl-2 apoptotic ratio in human endothelial cells.

Authors:  Karine Faucher; Hélène Rabinovitch-Chable; Jeanne Cook-Moreau; Guislaine Barrière; Franck Sturtz; Michel Rigaud
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

4.  Oxidized LDL up-regulates the ascorbic acid transporter SVCT2 in endothelial cells.

Authors:  James M May; Liying Li; Zhi-chao Qu
Journal:  Mol Cell Biochem       Date:  2010-06-13       Impact factor: 3.396

5.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

6.  Antioxidant diet supplementation starting 24 hours after exposure reduces radiation lethality.

Authors:  Stephen L Brown; Andrew Kolozsvary; Jianguo Liu; Kenneth A Jenrow; Samuel Ryu; Jae Ho Kim
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

7.  Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway.

Authors:  K Breitschopf; J Haendeler; P Malchow; A M Zeiher; S Dimmeler
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 8.  Role of vitamin C in the function of the vascular endothelium.

Authors:  James M May; Fiona E Harrison
Journal:  Antioxid Redox Signal       Date:  2013-05-29       Impact factor: 8.401

9.  Mitochondrial cholesterol transporter, StAR, inhibits human THP-1 monocyte-derived macrophage apoptosis.

Authors:  Qianming Bai; Xiaobo Li; Yanxia Ning; Fengdi Zhao; Lianhua Yin
Journal:  Lipids       Date:  2009-11-28       Impact factor: 1.880

10.  Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo.

Authors:  Qiang Tan; Jing Li; Han-wei Yin; Li-hui Wang; Wan-chen Tang; Fang Zhao; Xin-min Liu; Hui-hui Zeng
Journal:  Invest New Drugs       Date:  2009-03-07       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.